Researchers say that in the course of developing a new model for ovarian cancer, they've developed additional evidence that serous uterine cancer possibly begins in the fallopian tubes, not the uterus ...

Most uterine cancers have excellent five-year survival rates—up to 95% for localized cancer. Serous uterine cancer is an exception, with five-year survival rates of 35% to 50% for stage 1 or 2 cancer.

New research yields a novel method to use ultrasound to enhance machine learning's ability to accurately diagnose -- or rule out -- ovarian cancer. Although ovarian cancer is the deadliest type of ...

Researchers at Rice University have developed a mathematical model that enhances our understanding of ovarian aging and the timing of menopause, revealing mechanisms that could inform future ...

Homologous recombination deficiency (HRD) status and response to platinum-based chemotherapy and PARP inhibitors in Chinese patients with ovarian cancer.